At Farmaprojects, we help you turn healthcare opportunities into growth. Whether you are looking to strengthen your pipeline, access differentiated products, bring high-quality assets to Europe or explore new ways of partnering, you can tap into the capabilities of Farmaprojects and Polpharma Group. You can access an evolving portfolio — from generics to more differentiated and complex solutions, with a growing focus on complex injectables, including oligonucleotides and peptides, as well as ophthalmology and respiratory. And partnership goes beyond our portfolio. We can co-create opportunities through flexible models including out-licensing, co-development, co-investment and strategic collaborations — bringing together the right expertise and capabilities for each opportunity. If Europe is your next destination, you can benefit from our regulatory and market expertise, strong commercial presence across CEE and CIS, and a global network of leading pharmaceutical partners to help you navigate and expand across European markets. Behind all this is the strength of Polpharma Group: European R&D and manufacturing capabilities, vertical integration and more than 90 years of pharmaceutical experience. And if you are looking for your next professional challenge, you will find an international and entrepreneurial environment where people are encouraged to collaborate, challenge what is possible and help shape the future of healthcare. Whether you come to us as a customer, partner or future colleague, our approach is the same: we grow by creating value together.
Looking for a particular Farmaprojects employee's phone or email?
The Farmaprojects annual revenue was $14.8 million in 2026.
79 people are employed at Farmaprojects.
Farmaprojects is based in Barcelona, Catalonia.
The NAICS codes for Farmaprojects are [32, 3254, 32541, 325].
The SIC codes for Farmaprojects are [283, 28].